Boaz Adler

Director of Global Product Engagement

Boaz joined the team at Cytel in 2021 and is a member of the ​​Cytel Innovation Advisory Board. For more than a decade, he has served as a Solutions Consultant and Analyst for Life Sciences companies and Health Tech organizations. His interests are focused on tech and novel service innovations that contribute to more coherent and robust evidence generation across the drug development cycle.

At Cytel, Boaz enhances the connection between Cytel’s software development team and its clients and supports clients in clinical trial optimization projects using Cytel’s cutting-edge technology. He is passionate about his clients’ success and about the personal and professional success of his team and their contributions to the company.

Boaz has a BA in History and an MPA in Healthcare Finance and Policy from Baruch College.

Boaz Adler

Related Articles

Addressing Uncertainty in Survival Studies
Blog
April 29, 2025
Addressing Uncertainty in Survival Studies
Read More
Harnessing AI-Powered Tools for Clinical Trial Design Coding
Blog
February 27, 2025
Harnessing AI-Powered Tools for Clinical Trial Design Coding
Read More
Driving Innovation in Clinical Trial Design: Open Source, Commercial Software, and AI in 2025
Blog
January 23, 2025
Driving Innovation in Clinical Trial Design: Open Source, Commercial Software, and AI in 2025
Read More
Optimizing Interim Looks in Group Sequential Adaptive Study Designs
Blog
January 16, 2025
Optimizing Interim Looks in Group Sequential Adaptive Study Designs
Read More